Cargando…
Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
BACKGROUND: The aim of this study was to investigate the relationship between salivary concentration of the soluble fragment of the HER2 (human epidermal growth factor receptor) protein and its status in mammary tissues. METHODS: This case-control study was done in 27 breast cancer patients with no...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105270/ https://www.ncbi.nlm.nih.gov/pubmed/25053886 http://dx.doi.org/10.2147/OTT.S64230 |
_version_ | 1782327339383783424 |
---|---|
author | Laidi, Fatna Bouziane, Amal Lakhdar, Amina Khabouze, Samira Rhrab, Brahim Zaoui, Fatima |
author_facet | Laidi, Fatna Bouziane, Amal Lakhdar, Amina Khabouze, Samira Rhrab, Brahim Zaoui, Fatima |
author_sort | Laidi, Fatna |
collection | PubMed |
description | BACKGROUND: The aim of this study was to investigate the relationship between salivary concentration of the soluble fragment of the HER2 (human epidermal growth factor receptor) protein and its status in mammary tissues. METHODS: This case-control study was done in 27 breast cancer patients with no visible metastatic disease treated at the gynecology service, Maternity Souissi Hospital, Rabat, Morocco. Two groups were selected, ie, patients with positive and negative HER2 status in mammary tissue. The salivary HER2 protein concentration was assessed by enzyme-linked immunosorbent assay. The salivary HER2 concentration was compared between the HER2-positive and HER2-negative groups using the Mann-Whitney U test. A P-value <0.05 was considered to be statistically significant. RESULTS: No statistically significant difference in salivary HER2 protein expression was found between the case and control groups. There was also no significant difference in clinical characteristics according to positive and negative HER2 status (P>0.05), except for the progesterone hormone receptor which was statistically significant in both the case and control groups (P=0.047). CONCLUSION: According to our data, salivary expression of the HER2 receptor may not be a reliable alternative to tissue assessment. |
format | Online Article Text |
id | pubmed-4105270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-41052702014-07-22 Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status Laidi, Fatna Bouziane, Amal Lakhdar, Amina Khabouze, Samira Rhrab, Brahim Zaoui, Fatima Onco Targets Ther Original Research BACKGROUND: The aim of this study was to investigate the relationship between salivary concentration of the soluble fragment of the HER2 (human epidermal growth factor receptor) protein and its status in mammary tissues. METHODS: This case-control study was done in 27 breast cancer patients with no visible metastatic disease treated at the gynecology service, Maternity Souissi Hospital, Rabat, Morocco. Two groups were selected, ie, patients with positive and negative HER2 status in mammary tissue. The salivary HER2 protein concentration was assessed by enzyme-linked immunosorbent assay. The salivary HER2 concentration was compared between the HER2-positive and HER2-negative groups using the Mann-Whitney U test. A P-value <0.05 was considered to be statistically significant. RESULTS: No statistically significant difference in salivary HER2 protein expression was found between the case and control groups. There was also no significant difference in clinical characteristics according to positive and negative HER2 status (P>0.05), except for the progesterone hormone receptor which was statistically significant in both the case and control groups (P=0.047). CONCLUSION: According to our data, salivary expression of the HER2 receptor may not be a reliable alternative to tissue assessment. Dove Medical Press 2014-07-14 /pmc/articles/PMC4105270/ /pubmed/25053886 http://dx.doi.org/10.2147/OTT.S64230 Text en © 2014 Laidi et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed. |
spellingShingle | Original Research Laidi, Fatna Bouziane, Amal Lakhdar, Amina Khabouze, Samira Rhrab, Brahim Zaoui, Fatima Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status |
title | Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status |
title_full | Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status |
title_fullStr | Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status |
title_full_unstemmed | Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status |
title_short | Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status |
title_sort | salivary expression of soluble her2 in breast cancer patients with positive and negative her2 status |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105270/ https://www.ncbi.nlm.nih.gov/pubmed/25053886 http://dx.doi.org/10.2147/OTT.S64230 |
work_keys_str_mv | AT laidifatna salivaryexpressionofsolubleher2inbreastcancerpatientswithpositiveandnegativeher2status AT bouzianeamal salivaryexpressionofsolubleher2inbreastcancerpatientswithpositiveandnegativeher2status AT lakhdaramina salivaryexpressionofsolubleher2inbreastcancerpatientswithpositiveandnegativeher2status AT khabouzesamira salivaryexpressionofsolubleher2inbreastcancerpatientswithpositiveandnegativeher2status AT rhrabbrahim salivaryexpressionofsolubleher2inbreastcancerpatientswithpositiveandnegativeher2status AT zaouifatima salivaryexpressionofsolubleher2inbreastcancerpatientswithpositiveandnegativeher2status |